The European Regimen Accelerator For Tuberculosis (ERA4TB) Consortium met in Madrid during two days on the 29th and 30th of January 2020 to begin a new adventure.
The first ERA4TB Face to Face Meeting gathers representatives of the project consortium that integrates eight prestigious academic institutions (UC3M, UNIZAR, UU, EPFL, UKÖ, UNIPD, UPV, LUND), four non-profit organizations (IPP, IPL, iM4TB, BAR), eight public research organizations (FZB, CNR, IDMIT, SERMAS, PHE, NICE, SCI, IOS) and five highly skilled small-medium enterprises (SYNAPSE, C-Path, IBT, QPS, GRIT), together with three EFPIA members (GSK, EVT, JANSSEN), and three IMI2 Associated Partners (BMGF, TBA, DDU).
